insights_auto
Why is TNXP down 6.67%?
Dive Deeperchevron_right
TNXP:NASDAQ
Tonix Pharmaceuticals Holding Corp
$2.38
arrow_downward
-6.67%(-0.17) 1D
$2.39
arrow_upward
+0.22% (+0.0052)bedtimeAfter hours
Closed: Nov 20, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNXP...
Open
$2.56
High
$2.63
Low
$2.30
Mkt. cap
46.25M
Avg. vol.
1.11M
Volume
1.26M
52-wk high
$20.56
52-wk low
$2.30
EPS
-$12.23
Beta
1.90
Shares outstanding
19.43M
No. of employees
142
Open
$2.56
High
$2.63
Low
$2.30
Mkt. cap
46.25M
Avg. vol.
1.11M
Volume
1.26M
52-wk high
$20.56
52-wk low
$2.30
EPS
-$12.23
Beta
1.90
Shares outstanding
19.43M
No. of employees
142
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
The S&P 500 Just Entered Correction Territory. Here's What It Means for Investors Right Now.
Nacionale
·
2 hours ago
Is the stock market down for the year? Only the Nasdaq; the S&P 500 and Dow are barely up for 2026
Honolulu Star-Advertiser
·
7 hours ago
Wall Street rout pushes S&P 500, Dow into correction
Profile
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
About Tonix Pharmaceuticals Holding Corp
CEOSeth Lederman
Employees142
Founded2007
HeadquartersBerkeley Heights, New Jersey, United States
SectorHealth Care
IndustryBiotechnology
Websitetonixpharma.com